1-3 of 3
Julie Klinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunological Profile and Safety Evaluation in a 23-Week Single Dose Study in Cynomolgus Monkey with CHIR-12.12, a Fully Human Antagonist Anti-CD40 Antibody.

Ursula B. Jeffry, Mohammad Luqman, Kay Huh, Julie Klinger, Werner Frings, Nancy Turner
Journal: Blood
Blood (2004) 104 (11): 4638.
https://doi.org/10.1182/blood.V104.11.4638.4638
Published: 2004
Journal Articles

Antagonist Anti-CD40 Monoclonal Antibody, CHIR-12.12, Inhibits Growth of a Rituximab-Resistant NHL Xenograft Model and Achieves Synergistic Activity When Combined with Ineffective Rituximab.

Li Long, Ph.D., Xia Tong, M.Sc., Montesa Patawaran, B.Sc., Lea Aukerman, Ph.D., Julie Klinger, Ph.D., Bahija Jallal, Ph.D., Mohammad Luqman, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3281.
https://doi.org/10.1182/blood.V104.11.3281.3281
Published: 2004
Journal Articles

Safety Evaluation of an Fully Human Antagonist Anti-CD40 Antibody, CHIR-12.12, in a Dose Range-Finding Study in Cynomolgus Monkeys.

Ursula B. Jeffry, Kay Huh, Xia Tong, Julie Klinger, Werner Frings, Antje Fuchs, Nancy Turner, Mohammad Luqman
Journal: Blood
Blood (2004) 104 (11): 3282.
https://doi.org/10.1182/blood.V104.11.3282.3282
Published: 2004